Jump to navigation

Home
  • Blog
  • Contact
  • Donate
  • Intranet
  • Newsletter
Stronger health systems. Greater health impact.
  • Home
  • About MSH
    • Our Mission
    • Board & Team
      • Users (menu position rule)
    • Financial Data
      • Supporters
      • Annual Report
    • Careers
  • Our Expertise
    • Strengthening Health Systems
      • Global Health Security
      • Financing Health Services
      • Leadership, Management & Governance
      • Pharmaceutical Management
    • Packages of Care
      • HIV & AIDS
      • Tuberculosis
      • Malaria
      • Women's, Children's, and Adolescents' Health
    • Projects
    • Countries
      • Asia
      • Middle East and North Africa
      • Europe & Eurasia
      • Latin America & Caribbean
      • Sub-Saharan Africa
      • Fragile States
    • Advocacy
      • FCI Program of MSH
      • International Consortium for Emergency Contraception
      • Global Partnerships
    • Learning & Impact
    • MedSource
    • COVID-19: Responding to the Pandemic
  • Resources
    • Tools
    • Publications
    • LeaderNet
  • News & Stories
    • Press Room
      • Stories
      • Events
    • Partnerships

    You are here

    1. Home
    2. About MSH
    3. Board & Team
    4. Marian W. Wentworth
    Printer Friendly Version

    Marian W. Wentworth

    President and Chief Executive Officer

    Marian W. Wentworth is President and Chief Executive Officer of MSH. A leader in managing complex international public health initiatives globally and across diverse cultures, Wentworth uses her private sector and nonprofit acumen to address global health challenges from new vantage points. Since 2017, she has helped MSH make highly effective, sustainable systemic improvements in some of the globe’s most challenging environments. 

    Before coming to MSH, Wentworth managed global strategy for marketing, manufacturing, and research at Merck & Co for more than 25 years, including the company’s $6 billion dollar vaccines business. A champion for adolescent health, she led the global sales and marketing launch of the world’s first cervical cancer vaccine, Gardasil. She also managed adult vaccines for shingles, influenza, pneumococcal disease, hepatitis B, hepatitis A, and tetanus. Earlier in her career, Wentworth was a consultant in operations management at Arthur D. Little, Inc.

    Sharing her substantial experience in the vaccine market, Wentworth serves on the Value of Vaccination Research Network (VoVRN) Steering Committee and WHO’s Product Development for Vaccines Advisory Committee (PDVAC). As of January 2020, she is a visiting scholar at Drexel University's Dornsife School of Public Health.

    Wentworth has a B.A. in mathematics from Harvard University.

    Follow Wentworth on Twitter @MSHMarian

    Subscribe to Our Newsletter

    Sign Up

    Recent Posts by Marian W. Wentworth

    • Bringing the Private Sector to Public Health: How Business Innovation Can Improve Health Care Access

    • Fragile States Need Private Sector Allies

    • How can we each accelerate the pace of positive change for women in the workplace?

    • Safeguard a Vaccine Program with a Well-Planned Rollout

    Recent Journal Articles by Marian W. Wentworth

    • Building Momentum for Malaria Vaccine Research and Development: Key Considerations

    • Enhancing Public–Private Cooperation in Epidemic Preparedness and Response

    About MSH

    • Our Mission
    • Board & Team
    • Financial Data
    • Careers

    Resources

    • Tools
    • Publications
    • LeaderNet

    News & Stories

    • Press Room
    • Stories
    • Events

    Connect with MSH

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • RSS
    • Donate
    • Partner
    • Careers
    • Privacy and Terms
    • Contact Us
    • Newsletter

    Do Business with MSH

    • Commitment to Ethical Conduct
    • Outside Commercial Suppliers
    Copyright ©2021 Management Sciences for Health. All Rights Reserved.
    Site Design by Digital Loom / Hosted by EchoDitto / Login